{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:38:25Z","timestamp":1792103905667,"version":"4.4.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,3,22]],"date-time":"2016-03-22T00:00:00Z","timestamp":1458604800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,3,22]],"date-time":"2016-03-22T00:00:00Z","timestamp":1458604800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["2U01-DK065176-06"],"award-info":[{"award-number":["2U01-DK065176-06"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["5U01DK065193-04"],"award-info":[{"award-number":["5U01DK065193-04"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["2U01-DK065184-06"],"award-info":[{"award-number":["2U01-DK065184-06"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["2U01-DK065211-06"],"award-info":[{"award-number":["2U01-DK065211-06"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s10620-016-4121-6","type":"journal-article","created":{"date-parts":[[2016,3,22]],"date-time":"2016-03-22T04:13:31Z","timestamp":1458620011000},"page":"2406-2416","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":133,"title":["Amoxicillin\u2013Clavulanate-Induced Liver Injury"],"prefix":"10.1007","volume":"61","author":[{"name":"Drug-Induced Liver Injury Network (DILIN)","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1232-7986","authenticated-orcid":false,"given":"Andrew S.","family":"deLemos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwan","family":"Ghabril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don C.","family":"Rockey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiezhun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiman X.","family":"Barnhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Kleiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert L.","family":"Bonkovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,22]]},"reference":[{"key":"4121_CR1","unstructured":"Chalasani N, Fontana RJ, Bonkovsky HL, et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology. 2008;135:1924\u20131934, 1934 e1921\u20131924."},{"key":"4121_CR2","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.gastro.2005.05.006","volume":"129","author":"RJ Andrade","year":"2005","unstructured":"Andrade RJ, Lucena MI, Fernandez MC, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology. 2005;129:512\u2013521.","journal-title":"Gastroenterology"},{"key":"4121_CR3","unstructured":"Bjornsson ES, Bergmann OM, Bjornsson HK, Kvaran RB, Olafsson S. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology. 2013;144:1419\u20131425, 1425 e1411\u20131413; quiz e1419\u2013e1420."},{"key":"4121_CR4","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1053\/j.gastro.2013.12.032","volume":"146","author":"RJ Fontana","year":"2014","unstructured":"Fontana RJ. Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives. Gastroenterology. 2014;146:914\u2013928.","journal-title":"Gastroenterology"},{"key":"4121_CR5","doi-asserted-by":"crossref","unstructured":"Lewis JH, Zimmerman HJ. Drug- and chemical-induced cholestasis. Clin Liver Dis. 1999;3:433\u2013464, vii.","DOI":"10.1016\/S1089-3261(05)70079-9"},{"key":"4121_CR6","doi-asserted-by":"crossref","unstructured":"Mohi-ud-din R, Lewis JH. Drug- and chemical-induced cholestasis. Clin Liver Dis. 2004;8:95\u2013132, vii.","DOI":"10.1016\/S1089-3261(03)00124-7"},{"key":"4121_CR7","doi-asserted-by":"publisher","first-page":"6087","DOI":"10.3748\/wjg.13.6087","volume":"13","author":"SS Jakab","year":"2007","unstructured":"Jakab SS, West AB, Meighan DM, Brown RS Jr, Hale WB. Mycophenolate mofetil for drug-induced vanishing bile duct syndrome. World J Gastroenterol. 2007;13:6087\u20136089.","journal-title":"World J Gastroenterol"},{"key":"4121_CR8","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1055\/s-0029-1240005","volume":"29","author":"DE Kleiner","year":"2009","unstructured":"Kleiner DE. The pathology of drug-induced liver injury. Semin Liver Dis. 2009;29:364\u2013372.","journal-title":"Semin Liver Dis"},{"key":"4121_CR9","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1007\/s10620-005-2938-5","volume":"50","author":"RJ Fontana","year":"2005","unstructured":"Fontana RJ, Shakil AO, Greenson JK, Boyd I, Lee WM. Acute liver failure due to amoxicillin and amoxicillin\/clavulanate. Dig Dis Sci. 2005;50:1785\u20131790.","journal-title":"Dig Dis Sci"},{"key":"4121_CR10","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1345\/aph.18104","volume":"33","author":"DL Limauro","year":"1999","unstructured":"Limauro DL, Chan-Tompkins NH, Carter RW, Brodmerkel GJ Jr, Agrawal RM. Amoxicillin\/clavulanate-associated hepatic failure with progression to Stevens\u2013Johnson syndrome. Ann Pharmacother. 1999;33:560\u2013564.","journal-title":"Ann Pharmacother"},{"key":"4121_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2165\/00002018-200932010-00005","volume":"32","author":"RJ Fontana","year":"2009","unstructured":"Fontana RJ, Watkins PB, Bonkovsky HL, et al. Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct. Drug Saf. 2009;32:55\u201368.","journal-title":"Drug Saf"},{"key":"4121_CR12","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1038\/ajg.2015.283","volume":"110","author":"RJ Fontana","year":"2015","unstructured":"Fontana RJ, Hayashi PH, Barnhart H, et al. Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury. Am J Gastroenterol. 2015;110:1450\u20131459.","journal-title":"Am J Gastroenterol"},{"key":"4121_CR13","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1002\/hep.23577","volume":"51","author":"DC Rockey","year":"2010","unstructured":"Rockey DC, Seeff LB, Rochon J, et al. Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method. Hepatology. 2010;51:2117\u20132126.","journal-title":"Hepatology"},{"key":"4121_CR14","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1016\/j.cgh.2014.11.036","volume":"13","author":"SA Alqahtani","year":"2015","unstructured":"Alqahtani SA, Kleiner DE, Ghabril M, et al. Identification and characterization of cefazolin-induced liver injury. Clin Gastroenterol Hepatol. 2015;13:1328\u20131336.e2.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4121_CR15","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/hep.21324","volume":"44","author":"MI Lucena","year":"2006","unstructured":"Lucena MI, Andrade RJ, Fernandez MC, et al. Determinants of the clinical expression of amoxicillin\u2013clavulanate hepatotoxicity: a prospective series from Spain. Hepatology. 2006;44:850\u2013856.","journal-title":"Hepatology"},{"key":"4121_CR16","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/0016-5085(89)91633-8","volume":"96","author":"KR Reddy","year":"1989","unstructured":"Reddy KR, Brillant P, Schiff ER. Amoxicillin\u2013clavulanate potassium-associated cholestasis. Gastroenterology. 1989;96:1135\u20131141.","journal-title":"Gastroenterology"},{"key":"4121_CR17","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/S0016-5085(99)70404-X","volume":"117","author":"ML Hautekeete","year":"1999","unstructured":"Hautekeete ML, Horsmans Y, Van Waeyenberge C, et al. HLA association of amoxicillin\u2013clavulanate\u2013induced hepatitis. Gastroenterology. 1999;117:1181\u20131186.","journal-title":"Gastroenterology"},{"key":"4121_CR18","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/gut.33.3.368","volume":"33","author":"D Larrey","year":"1992","unstructured":"Larrey D, Vial T, Micaleff A, et al. Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases. Gut. 1992;33:368\u2013371.","journal-title":"Gut"},{"key":"4121_CR19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/cei.12558","volume":"180","author":"DM Foureau","year":"2015","unstructured":"Foureau DM, Walling TL, Maddukuri V, et al. Comparative analysis of portal hepatic infiltrating leukocytes in acute drug-induced liver injury, idiopathic autoimmune and viral hepatitis. Clin Exp Immunol. 2015;180:40\u201351.","journal-title":"Clin Exp Immunol"},{"key":"4121_CR20","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1053\/j.gastro.2011.04.001","volume":"141","author":"MI Lucena","year":"2011","unstructured":"Lucena MI, Molokhia M, Shen Y, et al. Susceptibility to amoxicillin\u2013clavulanate\u2013induced liver injury is influenced by multiple HLA class I and II alleles. Gastroenterology. 2011;141:338\u2013347.","journal-title":"Gastroenterology"},{"key":"4121_CR21","doi-asserted-by":"publisher","first-page":"e68111","DOI":"10.1371\/journal.pone.0068111","volume":"8","author":"C Stephens","year":"2013","unstructured":"Stephens C, Lopez-Nevot MA, Ruiz-Cabello F, et al. HLA alleles influence the clinical signature of amoxicillin\u2013clavulanate hepatotoxicity. PLoS One. 2013;8:e68111.","journal-title":"PLoS One"},{"key":"4121_CR22","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/ng.379","volume":"41","author":"AK Daly","year":"2009","unstructured":"Daly AK, Donaldson PT, Bhatnagar P, et al. HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet. 2009;41:816\u2013819.","journal-title":"Nat Genet"},{"key":"4121_CR23","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1097\/FPC.0b013e3283589a76","volume":"22","author":"TJ Urban","year":"2012","unstructured":"Urban TJ, Shen Y, Stolz A, et al. Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs. Pharmacogenet Genomics. 2012;22:784\u2013795.","journal-title":"Pharmacogenet Genomics"},{"key":"4121_CR24","first-page":"1298","volume":"141","author":"F de Haan","year":"1997","unstructured":"de Haan F. Stricker BH [Liver damage associated with the combination drug amoxicillin-clavulanic acid (Augmentin)]. Ned Tijdschr Geneeskd. 1997;141:1298\u20131301.","journal-title":"Ned Tijdschr Geneeskd"},{"key":"4121_CR25","doi-asserted-by":"crossref","first-page":"638","DOI":"10.5694\/j.1326-5377.1995.tb126049.x","volume":"162","author":"JA Thomson","year":"1995","unstructured":"Thomson JA, Fairley CK, Ugoni AM, et al. Risk factors for the development of amoxycillin-clavulanic acid associated jaundice. Med J Aust. 1995;162:638\u2013640.","journal-title":"Med J Aust"},{"key":"4121_CR26","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1136\/gut.47.5.717","volume":"47","author":"J O\u2019Donohue","year":"2000","unstructured":"O\u2019Donohue J, Oien KA, Donaldson P, et al. Co-amoxiclav jaundice: clinical and histological features and HLA class II association. Gut. 2000;47:717\u2013720.","journal-title":"Gut"},{"key":"4121_CR27","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1001\/archinte.156.12.1327","volume":"156","author":"LA Garcia Rodriguez","year":"1996","unstructured":"Garcia Rodriguez LA, Stricker BH, Zimmerman HJ. Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid. Arch Intern Med. 1996;156:1327\u20131332.","journal-title":"Arch Intern Med"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-016-4121-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-016-4121-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-016-4121-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-016-4121-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T10:34:09Z","timestamp":1589711649000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-016-4121-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,22]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["4121"],"URL":"https:\/\/doi.org\/10.1007\/s10620-016-4121-6","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,22]]},"assertion":[{"value":"11 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors certify that they have no financial arrangements (e.g., consultancies, stock ownership, equity interests, patent-licensing arrangements, research support, honoraria, etc.) with a company whose product figures prominently in this manuscript or with a company making a competing product.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}